Prognostic significance of HPV status in postoperative squamous-cell carcinoma of the head and neck

被引:1
作者
Bertke, Matthew H. [1 ]
Shaughnessy, Joseph N. [1 ]
Forsthoefel, Matthew K. [1 ]
Cash, Liz D. [2 ]
Silverman, Craig L. [1 ]
Bumpous, Jefrey M. [2 ]
Potts, Kevin L. [2 ]
Redman, Rebecca A. [3 ]
Perez, Cesar A. [3 ]
Dunlap, Neal E. [1 ]
机构
[1] Univ Louisville, Sch Med, Dept Radiat Oncol, Louisville, KY 40292 USA
[2] Univ Louisville, Sch Med, Dept Otolaryngol HNS & Commun Disorders, Louisville, KY 40292 USA
[3] Univ Louisville, Sch Med, Dept Med Oncol, Louisville, KY 40292 USA
关键词
D O I
10.12788/jcso.0252
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background There are limited data on the prognostic significance of human papillomavirus (HPV) status in relation to traditional risk factors for head and neck squamous-cell carcinoma (HNSCC) in the postoperative setting. Objective To clarify the impact of HPV status on the risk for HNSCC in the postoperative setting. Methods We retrospectively evaluated an institutional cohort of 128 patients with HNSCC patients who had been treated with definitive surgery with or without adjuvant radiotherapy or chemoradiotherapy. Patient, disease, and treatment factors were analyzed as potential prognostic indicators. Results Lymph node extracapsular extension (ECE), perineural invasion (PNI), and lymphovascular space invasion (LVSI) positivity predicted poorer locoregional control (LRC), disease-free survival (DFS), and overall survival (OS). Positive margins related to poorer DFS and OS. HPV status alone did not predict LRC, DFS, or OS. Compared with patients who were HPV-positive and ECE-negative, both HPV-positive and HPV-negative patients with ECE experienced significantly poorer OS (78.6%, 60%, and 43.7%, respectively; P=.010 and P=.018, respectively). Limitations Retrospective, single-institution study; small patient cohort; short follow-up time Conclusion The influence of HPV in postoperative HNSCC seems limited compared with traditional risk factors such as ECE, LVSI, and PNI. De-escalation of postoperative treatment based on HPV status alone should be approached with caution.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 24 条
  • [1] Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
    Ang, K. Kian
    Harris, Jonathan
    Wheeler, Richard
    Weber, Randal
    Rosenthal, David I.
    Nguyen-Tan, Phuc Felix
    Westra, William H.
    Chung, Christine H.
    Jordan, Richard C.
    Lu, Charles
    Kim, Harold
    Axelrod, Rita
    Silverman, C. Craig
    Redmond, Kevin P.
    Gillison, Maura L.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) : 24 - 35
  • [2] Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer
    Ang, KK
    Trotti, A
    Brown, BW
    Garden, AS
    Foote, RL
    Morrison, WH
    Geara, FB
    Klotch, DW
    Goepfert, H
    Peters, LJ
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (03): : 571 - 578
  • [3] Defining risk levels in locally advanced head and neck cancers:: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (#9501)
    Bernier, J
    Cooper, JS
    Pajak, TF
    van Glabbeke, M
    Bourhis, J
    Forastiere, A
    Ozsahin, EM
    Jacobs, JR
    Jassem, J
    Ang, KK
    Lefèbvre, JL
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2005, 27 (10): : 843 - 850
  • [4] Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer
    Bernier, J
    Domenge, C
    Ozsahin, M
    Matuszewska, K
    Lefèbvre, JL
    Greiner, RH
    Giralt, J
    Maingon, P
    Rolland, F
    Bolla, M
    Cognetti, F
    Bourhis, J
    Kirkpatrick, A
    van Glabbeke, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) : 1945 - 1952
  • [5] Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck
    Bonner, JA
    Harari, PM
    Giralt, J
    Azarnia, N
    Shin, DM
    Cohen, RB
    Jones, CU
    Sur, R
    Raben, D
    Jassem, J
    Ove, R
    Kies, MS
    Baselga, J
    Youssoufian, H
    Amellal, N
    Rowinsky, EK
    Ang, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 567 - 578
  • [6] Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience
    Brockstein, B
    Haraf, DJ
    Rademaker, AW
    Kies, MS
    Stenson, KM
    Rosen, F
    Mittal, BB
    Pelzer, H
    Fung, BB
    Witt, ME
    Wenig, B
    Portugal, L
    Weichselbaum, RW
    Vokes, EE
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (08) : 1179 - 1186
  • [7] Phase 2 Trial of De-intensified Chemoradiation Therapy for Favorable-Risk Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma
    Chera, Bhishamjit S.
    Amdur, Robert J.
    Tepper, Joel
    Qaqish, Bahjat
    Green, Rebecca
    Aumer, Shannon L.
    Hayes, Neil
    Weiss, Jared
    Grilley-Olson, Juneko
    Zanation, Adam
    Hackman, Trevor
    Funkhouser, William
    Sheets, Nathan
    Weissler, Mark
    Mendenhall, William
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (05): : 976 - 985
  • [8] p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
    Chung, Christine H.
    Zhang, Qiang
    Kong, Christina S.
    Harris, Jonathan
    Fertig, Elana J.
    Harari, Paul M.
    Wang, Dian
    Redmond, Kevin P.
    Shenouda, George
    Trotti, Andy
    Raben, David
    Gillison, Maura L.
    Jordan, Richard C.
    Quynh-Thu Le
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (35) : 3930 - U212
  • [9] Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck
    Cooper, Jay S.
    Zhang, Qiang
    Pajak, Thomas F.
    Forastiere, Arlene A.
    Jacobs, John
    Saxman, Scott B.
    Kish, Julie A.
    Kim, Harold E.
    Cmelak, Anthony J.
    Rotman, Marvin
    Lustig, Robert
    Ensley, John F.
    Thorstad, Wade
    Schultz, Christopher J.
    Yom, Sue S.
    Ang, K. Kian
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (05): : 1198 - 1205
  • [10] Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck
    Cooper, JS
    Pajak, TF
    Forastiere, AA
    Jacobs, J
    Campbell, BH
    Saxman, SB
    Kish, JA
    Kim, HE
    Cmelak, AJ
    Rotman, M
    Machtay, M
    Ensley, JF
    Chao, KSC
    Schultz, CJ
    Lee, N
    Fu, KK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) : 1937 - 1944